Departments of Epidemiology (KTM, JC, JD, MK-W, LAB, JH) and Global Health Systems and Development (LS), Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana; Department of Medicine (JC, MK-W, JH), Tulane University School of Medicine, New Orleans, Louisiana; Center for Health Research (MK-W), Ochsner Health System, New Orleans, Louisiana; and Institute for Clinical Effectiveness and Health Policy (AR, VI, AB, RP, FA), Buenos Aires, Argentina.
Am J Med Sci. 2014 Aug;348(2):139-45. doi: 10.1097/MAJ.0000000000000298.
Although the efficacy and effectiveness of lifestyle modifications and antihypertensive pharmaceutical treatment for the prevention and control of hypertension and concomitant cardiovascular disease have been demonstrated in randomized controlled trials, this scientific knowledge has not been fully applied in the general population, especially in low-income communities. This article summarizes interventions to improve hypertension management and describes the rationale and study design for a cluster randomized trial testing whether a comprehensive intervention program within a national public primary care system will improve hypertension control among uninsured hypertensive men and women and their families. We will recruit 1,890 adults from 18 clinics within a public primary care network in Argentina. Clinic patients with uncontrolled hypertension, their spouses and hypertensive family members will be enrolled. The comprehensive intervention program targets the primary care system through health care provider education, a home-based intervention among patients and their families (home delivery of antihypertensive medication, self-monitoring of blood pressure [BP], health education for medication adherence and lifestyle modification) conducted by community health workers and a mobile health intervention. The primary outcome is net change in systolic BP from baseline to month 18 between intervention and control groups among hypertensive study participants. The secondary outcomes are net change in diastolic BP, BP control and cost-effectiveness of the intervention. This study will generate urgently needed data on effective, practical and sustainable intervention programs aimed at controlling hypertension and concomitant cardiovascular disease in underserved populations in low- and middle-income countries.
尽管生活方式改变和抗高血压药物治疗在预防和控制高血压和伴随的心血管疾病方面的疗效和有效性已在随机对照试验中得到证实,但这一科学知识尚未在普通人群中得到充分应用,尤其是在低收入社区。本文总结了改善高血压管理的干预措施,并描述了一项集群随机试验的基本原理和研究设计,该试验旨在测试在国家公共初级保健系统内实施综合干预方案是否会改善未参保高血压男女及其家庭的高血压控制情况。我们将从阿根廷一个公共初级保健网络的 18 个诊所招募 1890 名成年人。诊所中血压控制不佳的患者及其配偶和高血压家庭成员将被纳入研究。综合干预方案通过医护人员教育、以患者及其家庭为基础的家庭干预(高血压药物的上门配送、血压自我监测、药物依从性和生活方式改变的健康教育)和移动医疗干预来针对初级保健系统。主要结局指标是高血压研究参与者中干预组和对照组之间从基线到第 18 个月收缩压的净变化。次要结局指标是舒张压、血压控制和干预的成本效益的净变化。这项研究将为中低收入国家服务不足人群控制高血压和伴随的心血管疾病的有效、实用和可持续干预方案提供急需的数据。